Abstracts

Citation

Deborah Persaud, M.D., Carrie Ziemniak, Kimberly Ferguson, Jie (Ellen) Chen, M.S., Stephen J. Gange, Barbara E. Heckman, B.S., Paul Palumbo, M.D., Ellen Gould Chadwick, M.D. Delayed clearance of latently infected CD4+ T cells in HIV-1-infected infants initiating HAART younger than 6 months of age. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Brian Robbins, Ph.D., Peter Havens, M.D., Edmund Capparelli, Pharm.D., Ellen Gould Chadwick, M.D., Ram Yogev, M.D., Leslie Serchuck, M.D., Carol J. Worrell, M.D., Carmelita Alvero, Barbara E. Heckman, B.S. Pharmacokinetics (PK) of high-dose lopinavir (LPV)/Ritonavir (r) with and without saquinavir (SQV) or non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV infected pediatric and adolescent patients previously treated with protease inhibitors (P. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Brookie M. Best, Pharm.D., Alice M. Stek, M.D., ChengCheng Hu, Ph.D., Edmund Capparelli, Pharm.D., Diane Holland, M.Phil., Sandra K. Burchett, M.D., M.S., Elizabeth (Betsy) Smith, M.D., Mark Mirochnick, M.D. Nelfinavir pharmacokinetics (625 mg tablets) during the third trimester of pregnancy and post-partum. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

William T. Shearer, M.D., Ph.D., Jaime G. Deville, M.D., Pearl Samson, M.S., John ( Jack ) Moye, Jr., M.D., Joseph A. Church, M.D., Hans ML Spiegel, M.D., Ph.D., Terence Fenton, Ed.D., Elizabeth (Betsy) Smith, M.D., Bobbie L. Graham, B.S., Courtney V. Fletcher, Pharm.D. Non-linear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 observed in HIV-1-infected children. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Jorge Pinto, M.D., D.Sc., Brian Robbins, Ph.D., Jie (Ellen) Chen, M.S., Leslie Serchuck, M.D., Edmund Capparelli, Pharm.D., Ram Yogev, M.D., Paul Palumbo, M.D., John H. Rodman, Pharm.D., Barbara E. Heckman, B.S., Ellen Gould Chadwick, M.D. Pharmacokinetics and 24-week efficacy and safety of lopinavir/ritonavir in HIV-1-infected infants < 6 weeks of age. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Miriam Chernoff, Ph.D., Sharon Appelbaum Nachman, M.D., Paige L. Williams, Ph.D., Pim Brouwers, Ph.D., Jerry D. Heston, M.D., Janice Hodge, R.N., B.S., Vincenza M. Di Poalo, Nagamah Sandra Deygoo, Kenneth D. Gadow, Ph.D. Psychotropic drug therapy and psychiatric symptoms in HIV-infected and uninfected children and adolescents enrolled in PACTG P1055. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Francesca Aweeka, Pharm.D., Alice M. Stek, M.D., Brookie M. Best, Pharm.D., ChengCheng Hu, Ph.D., Diane Holland, M.Phil., Ashwaq E. Hermes, Pharm.D., Sandra K. Burchett, M.D., M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Mark Mirochnick, M.D., Edmund Capparelli, Pharm.D. Lopinavir protein binding during pregnancy. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Akihiko Saitoh, M.D., Elizabeth Sarles, Edmund Capparelli, Pharm.D., Francesca Aweeka, Pharm.D., Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. CYP2B6-G516T genetic variants affect the pharmacokinetics of nevirapine and clinical responses in HIV-1 infected children receiving HAART. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Adriana Weinberg, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Ruth E. Dickover, Ph.D., Julie A. Patterson, B.S., Howard Gutzman, B.S., Mobeen H. Rathore, M.D., Ross E. McKinney, Jr., M.D. Delayed recovery of HIV-specific CD4-mediated immunity in HIV-infected children on their first HAART regimen (PACTG P1021). Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Richard M. Rutstein, M.D., Pearl Samson, M.S., Jennifer J. Kiser, Pharm.D., Courtney V. Fletcher, Pharm.D., Bobbie L. Graham, B.S., Steven M. Schnittman, M.D., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Terence Fenton, Ed.D., Grace M. Aldrovandi, MD. The PACTG 1020A protocol: atazanavir with or without ritonavir in HIV-infected infants, children, and adolescents. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.